JP2023537904A5 - - Google Patents

Info

Publication number
JP2023537904A5
JP2023537904A5 JP2023507761A JP2023507761A JP2023537904A5 JP 2023537904 A5 JP2023537904 A5 JP 2023537904A5 JP 2023507761 A JP2023507761 A JP 2023507761A JP 2023507761 A JP2023507761 A JP 2023507761A JP 2023537904 A5 JP2023537904 A5 JP 2023537904A5
Authority
JP
Japan
Prior art keywords
raav
approximately
day
dose
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507761A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537904A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045443 external-priority patent/WO2022035900A1/en
Publication of JP2023537904A publication Critical patent/JP2023537904A/ja
Publication of JP2023537904A5 publication Critical patent/JP2023537904A5/ja
Pending legal-status Critical Current

Links

JP2023507761A 2020-08-10 2021-08-10 神経変性障害のための遺伝子療法 Pending JP2023537904A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063063852P 2020-08-10 2020-08-10
US63/063,852 2020-08-10
PCT/US2021/045443 WO2022035900A1 (en) 2020-08-10 2021-08-10 Gene therapies for neurodegenerative disorders

Publications (2)

Publication Number Publication Date
JP2023537904A JP2023537904A (ja) 2023-09-06
JP2023537904A5 true JP2023537904A5 (cg-RX-API-DMAC7.html) 2024-08-21

Family

ID=77951788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507761A Pending JP2023537904A (ja) 2020-08-10 2021-08-10 神経変性障害のための遺伝子療法

Country Status (10)

Country Link
US (1) US20230346979A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192517A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023537904A (cg-RX-API-DMAC7.html)
KR (1) KR20230066360A (cg-RX-API-DMAC7.html)
CN (1) CN116437968A (cg-RX-API-DMAC7.html)
AU (1) AU2021325891A1 (cg-RX-API-DMAC7.html)
CA (1) CA3190864A1 (cg-RX-API-DMAC7.html)
IL (1) IL300409A (cg-RX-API-DMAC7.html)
MX (1) MX2023001564A (cg-RX-API-DMAC7.html)
WO (1) WO2022035900A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3692158A4 (en) 2017-10-03 2021-08-04 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMAL DISEASES
HRP20251506T1 (hr) 2019-04-10 2026-01-02 Prevail Therapeutics, Inc. Genska terapija za lizosomske poremećaje
CN116672341A (zh) * 2022-02-23 2023-09-01 中国科学院上海药物研究所 雷帕霉素在治疗渐冻症和额颞叶痴呆中的应用
CN120077057A (zh) 2022-10-04 2025-05-30 伊莱利利公司 Trem2相关疾病和病症的基因治疗
AR131035A1 (es) 2022-11-11 2025-02-12 Lilly Co Eli Ácidos nucleicos sintéticos que incluyen constructos promotores dirigidos a astrocitos y métodos de uso de los mismos
AU2023378899A1 (en) * 2022-11-13 2025-06-26 Alexion Pharma International Operations Limited Gene therapy for frontotemporal dementia
WO2024163823A1 (en) * 2023-02-02 2024-08-08 Shape Therapeutics Inc. Tissue-specific enhancers for regulating transcription
KR20250158063A (ko) * 2023-03-16 2025-11-05 젠자임 코포레이션 건식 연령-관련 황반 변성의 치료
WO2025251041A1 (en) * 2024-05-31 2025-12-04 Bluerock Therapeutics Lp METHODS AND COMPOSITIONS FOR TREATING PROGRANULIN DEFICIENCIES USING iPSC-DERIVED CELLS
WO2026043765A1 (en) 2024-08-21 2026-02-26 Eli Lilly And Company Engineered regulatory splice elements for gene therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2385679T3 (es) 2006-08-24 2012-07-30 Virovek, Inc. Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
CN107002096A (zh) * 2014-10-06 2017-08-01 阿罗根有限公司 基于aav的基因疗法
KR20220082100A (ko) * 2015-05-15 2022-06-16 리젠츠 오브 더 유니버시티 오브 미네소타 중추 신경계로의 아데노-연관 치료적 전달
CA3016314A1 (en) * 2016-03-02 2017-09-08 Julianne REIDERS Therapy for frontotemporal dementia
CA3012699C (en) 2016-04-21 2023-11-21 Virovek, Inc Aav production in insect cells, methods and compositions therefor
BR112019023303A2 (pt) * 2017-05-11 2020-06-16 The Trustees Of The University Of Pennsylvania Terapia de gene para lipofuscinoses ceroides neuronais
CA3068328A1 (en) * 2017-07-06 2019-01-10 The Trustees Of The University Of Pennsylvania Aav9-mediated gene therapy for treating mucopolysaccharidosis type i
EP3692158A4 (en) * 2017-10-03 2021-08-04 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMAL DISEASES
MX2020004005A (es) 2017-10-03 2020-10-05 Prevail Therapeutics Inc Terapias genicas para los trastornos lisosomales.
CN111542549A (zh) 2017-10-03 2020-08-14 普利维尔治疗公司 用于溶酶体障碍的基因疗法
HRP20251506T1 (hr) 2019-04-10 2026-01-02 Prevail Therapeutics, Inc. Genska terapija za lizosomske poremećaje

Similar Documents

Publication Publication Date Title
JP2023537903A5 (cg-RX-API-DMAC7.html)
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
US12440580B2 (en) Adeno-associated virus vectors encoding modified G6PC and uses thereof
JP2021522273A5 (cg-RX-API-DMAC7.html)
JP2022526021A5 (cg-RX-API-DMAC7.html)
US20040142416A1 (en) Treatment for phenylketonuria
JP2022523766A5 (cg-RX-API-DMAC7.html)
CN117512014A (zh) 酸性α-葡萄糖苷酶变体及其用途
JP2021533805A5 (cg-RX-API-DMAC7.html)
JP2022526823A5 (cg-RX-API-DMAC7.html)
JP2022520232A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
WO2007120533A2 (en) Minigene expression cassette
WO2020223362A1 (en) Compositions useful for treatment of pompe disease
JP2023503850A5 (cg-RX-API-DMAC7.html)
JP2024545183A (ja) ウイルスベクターによりbag-3関連心筋症を処置するための方法および組成物
JP2025138648A (ja) Cln3ポリヌクレオチドのアデノ随伴ウイルス送達
WO2019200286A1 (en) Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
US20240058477A1 (en) Methods and compositions for treatment of friedreich's ataxia
JP2023539247A (ja) Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用
JP2025509828A (ja) ウイルスベクターによるtnnt2関連心筋症を処置するための方法および組成物
JP7693676B2 (ja) ハンター病治療用のアデノ随伴ウイルスベクター
JP2025509864A (ja) ウイルスベクターによりrbm20関連心筋症を処置するための方法および組成物
JP7674391B2 (ja) グルコース-6-ホスファターゼ(G6Pase-a)をコードする遺伝子治療用ベクター
US20240207370A1 (en) Gene therapy for bcaa modulation in maple syrup urine disease (msud)